Factors Associated With Postreperfusion Syndrome in Living Donor Liver Transplantation: A Retrospective Study

被引:4
|
作者
Umehara, Kaoru [1 ]
Karashima, Yuji [1 ]
Yoshizumi, Tomoharu [2 ]
Yamaura, Ken [3 ]
机构
[1] Kyushu Univ Hosp, Operating Rooms, 3 1 1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Dept Surg & Sci, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Anesthesiol & Crit Care Med, Fukuoka, Japan
来源
ANESTHESIA AND ANALGESIA | 2022年 / 135卷 / 02期
关键词
REPERFUSION SYNDROME; MANAGEMENT; PREDICTORS; FAILURE;
D O I
10.1213/ANE.0000000000006002
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: Postreperfusion syndrome (PRS) after portal vein reperfusion during liver transplantation (LT) has been reported to cause rapid hemodynamic changes and is associated with a prolonged postoperative hospital stay, renal failure, and increased mortality. Although there are some reports on risk factors for PRS in brain-dead donor LT, there are a few reports on those in living donor LT. Therefore, we retrospectively reviewed the factors associated with PRS to contribute to the anesthetic management so as to reduce PRS during living donor LT. METHODS: After approval by the ethics committee of our institution, 250 patients aged >= 20 years who underwent living donor LT at our institution between January 2013 and September 2018 were included in the study. A decrease in mean arterial pressure of >= 30% within 5 minutes after portal vein reperfusion was defined as PRS, and estimates and odds ratio (OR) for PRS were calculated using logistic regression. The backward method was used for variable selection in the multivariable analysis. RESULTS: Serum calcium ion concentration before reperfusion (per 0.1 mmol/L increase; OR, 0.74; 95% confidence interval (CI), 0.60-0.95; P < .001), preoperative echocardiographic left ventricular end-diastolic diameter (per 1-mm increase: OR, 0.90; 95% CI, 0.85-0.95; P < .001, men [versus women: OR, 2.45; 95% CI, 1.26-4.75; P = .008]), mean pulmonary artery pressure before reperfusion (restricted cubic spline, P = .003), anhepatic period (restricted cubic spline, P = .02), and graft volume to standard liver volume ratio (restricted cubic spline, P = .03) were significantly associated with PRS. CONCLUSIONS: In living donor LT, male sex and presence of small left ventricular end-diastolic diameter, large graft volume, and long anhepatic period are associated with PRS, and a high calcium ion concentration and low pulmonary artery pressure before reperfusion are negatively associated with PRS.
引用
收藏
页码:354 / 361
页数:8
相关论文
共 50 条
  • [41] Incidence and Predictive Factors of Postreperfusion Syndrome in a Multicenter Liver Transplant Study
    Sabate, A.
    Blasi, A.
    Gutierrez, R.
    Beltran, J.
    Costa, M.
    Sanahuja, J.
    Reyes, R.
    Torres, F.
    TRANSPLANTATION, 2017, 101 (05) : 185 - 186
  • [42] Diagnosis, Incidence, Predictors and Management of Postreperfusion Syndrome in Pediatric Deceased Donor Liver Transplantation: A Single-Center Study
    Zhang, Liang
    Tian, Ming
    Xue, Fushan
    Zhu, Zhijun
    ANNALS OF TRANSPLANTATION, 2018, 23 : 334 - 344
  • [43] Hemodynamic Recovery Following Postreperfusion Syndrome in Liver Transplantation
    Fukazawa, Kyota
    Yamada, Yoshitsugu
    Gologorsky, Edward
    Arheart, Kristopher L.
    Pretto, Ernesto A., Jr.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (04) : 994 - 1002
  • [44] Predictive factors associated with re-exploration for hemostasis in living donor liver transplantation
    Wu, Shao-Chun
    Chen, Chao-Long
    Wang, Chih-Hsien
    Huang, Chia-Jung
    Cheng, Kwok-Wai
    Shih, Tsung-Hsiao
    Yang, Johnson Chia-Shen
    Jawan, Bruno
    ANNALS OF TRANSPLANTATION, 2012, 17 (04) : 64 - 71
  • [45] Exploring safety and efficacy of rivaroxaban after living donor liver transplantation: a retrospective study
    Khan, Bilal Ahmed
    Khalid, Abdullah
    Saeed, Zubair
    Ihsan-ul-Haq
    Khan, Muhammad Yasir
    Rashid, Sohail
    Naveed, Ammara
    Dar, Faisal Saud
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [46] Exploring safety and efficacy of rivaroxaban after living donor liver transplantation: a retrospective study
    Bilal Ahmed Khan
    Abdullah Khalid
    Zubair Saeed
    Muhammad Yasir Ihsan-ul-Haq
    Sohail Khan
    Ammara Rashid
    Faisal Saud Naveed
    Langenbeck's Archives of Surgery, 408
  • [47] CONTRIBUTORS TO POSTREPERFUSION SYNDROME (PRS) IN LIVER-TRANSPLANTATION
    ACOSTA, F
    DIAZ, J
    CONTERAS, RF
    MARQUEZ, MG
    RODRIGUEZ, MA
    VIDAL, JL
    ROBLES, R
    BUENO, FS
    RAMIREZ, P
    PARRILLA, P
    BRITISH JOURNAL OF SURGERY, 1995, 82 : 88 - 88
  • [48] Postreperfusion syndrome, hyperkalemia and machine perfusion in liver transplantation
    Patrono, Damiano
    Romagnoli, Renato
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [49] α-lipoic acid reduces postreperfusion syndrome in human liver transplantation - a pilot study
    Casciato, Paola
    Ambrosi, Nella
    Caro, Fiorella
    Vazquez, Monica
    Mullen, Eduardo
    Gadano, Adrian
    de Santibanes, Eduardo
    de Santibanes, Martin
    Zandomeni, Marcos
    Chahdi, Magali
    Lazarte, Julio C.
    Biagiola, David A.
    Iaquinandi, Juan Cruz
    Santofimia-Castano, Patricia
    Iovanna, Juan
    Incardona, Claudio
    Chuluyan, Eduardo
    TRANSPLANT INTERNATIONAL, 2018, 31 (12) : 1357 - 1368
  • [50] Association Between Flushed Fluid Potassium Concentration and Severe Postreperfusion Syndrome in Deceased Donor Liver Transplantation
    Zhang, Liang
    Tian, Ming
    Sun, Liying
    Zhu, Zhijun
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5158 - 5167